Universal Health Services Stock: Analyst Estimates & Ratings
Analysts covering Universal Health Services (UHS) have a consensus rating of 'Moderate Buy,' with six 'Strong Buy' ratings, 13 'Holds,' and one 'Moderate Sell.' The sentiment has shifted from seven 'Moderate Buy' ratings two months ago. RBC Capital analyst Ben Hendrix maintained a 'Sector-Perform' rating, lowering the price target to $183 from $190, implying a 7.3% upside. The mean price target is $192.24, a 9% premium to the current price, while the highest target is $290, suggesting a 64.4% up
How this was made
The 30-second read
Why it matters
Analyst consensus and price target revisions could drive short-term buying interest.
Market read
Analyst upgrades and higher price targets may support a modest rally in UHS shares.
What to watch
Potential impact of upcoming earnings and regulatory changes not reflected in current targets.
Background
Universal Health Services (UHS) is a leading provider of acute care and behavioral health services.
Ticker impact
Analyst consensus shows a Moderate Buy with price targets up to $290, indicating potential upside.
Modest upside of 5-10% if market reacts to higher targets.
Multiple analysts raised targets; consensus remains supportive, but no new catalyst beyond rating change.
Market effects
Healthcare services sector may see modest uplift as analysts raise targets.
U.S. market could see slight positive bias in hospital REITs.
Limited to U.S. healthcare investors.
Counterpoint
Price targets may be overly optimistic given sector headwinds; hold rating suggests caution.
Key entities
- Analyst FirmRBC Capital
Trimmed price target to $183, maintaining Sector-Perform rating.
